摘要 |
A controlled release dosage form containing lercanidipine, or a salt thereof, a performance-enhancing acid, and at least one other pharmaceutical excipient exhibits enhanced in vitro dissolution of lercanidipine, enhanced storage stability based upon the reduced degradation of lercanidipine, and/or enhanced in vivo bioavailability of lercanidipine as compared to an otherwise similar controlled release dosage form excluding the performance-enhancing acid but containing the same amount of lercanidipine. |
申请人 |
OSMOTICA COSTA RICA, SOCIEDAD ANONIMA;ABALO, ESTEBAN A.;RICCI, MARCELO, A.;MEYER, GLENN, A.;CARRAUD, PABLO F. A. |
发明人 |
ABALO, ESTEBAN A.;RICCI, MARCELO, A.;MEYER, GLENN, A.;CARRAUD, PABLO F. A. |